[{"type": "title", "data": "ED Adult Frostbite Grade 2 to 4"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "INCLUSION CRITERIA: grade 2 to 4 frostbite.Assess severity as per Frostbite Treatment Algorithm: <A href=&quot;http://docushare.northernhealth.ca/docushare/dsweb/Get/Document-492425/16-020-7010%20Frostbite%20Treatment%20Algorithm.pdf&quot; target=_blank>http://docushare.northernhealth.ca/docushare/dsweb/Get/Document-492425/16-020-7010%20Frostbite%20Treatment%20Algorithm.pdf</A>Patient is eligible for iloprost and alteplase as applicable (see contraindications)For grade 1 frostbite treatment, refer to ED Adult Frostbite Grade 1. "}, {"type": "note", "data": "Ensure&nbsp;diagnosis is documented. - grade 2 frostbite (treat with iloprost only) - grade 3 frostbite (treat with iloprost only) - grade 4 frostbite (treat with iloprost, enoxaparin and alteplase orders) Note: treatment of hypothermia and/or severe trauma takes priority. "}, {"type": "note", "data": "Contraindications for iloprost: - pregnancy, lactation - conditions where the effect of iloprost on platelets might increase risk of hemorrhage (e.g. active peptic ulcers, trauma, intracranial hemorrhage) - severe coronary heart disease or unstable angina - myocardial infarction within the last 6 months - acute or chronic congestive heart failure (NYHA II-IV) - severe arrhythmias - suspected pulmonary congestion "}, {"type": "note", "data": "Special Precautions for iloprost - surgery should not be delayed in patients requiring urgent amputation (e.g. in infected gangrene) - iloprost elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis - in patients with low blood pressure, care should be taken to avoid further hypotension and patients with significant heart disease should be closely monitored - monitor for possible orthostatic hypotension in patients getting up from the lying to an upright position after the end of administration - for patients with a cerebrovascular event (e.g. transient ischemic attack, stroke) within the last 3 months, a careful benefit-risk evaluation should be undertaken - currently only sporadic reports of use in children and adolescents are available - the perivascular infusion of undiluted iloprost can lead to local changes at the injection site - oral ingestion and contact with mucous membranes must be avoided; on contact with the skin, iloprost may provoke long-lasting erythema "}, {"type": "note", "data": "ABSOLUTE CONTRAINDICATIONS FOR ALTEPLASEDo NOT use if any of the following present:- history of any intracranial hemorrhage- history of ischemic stroke within the preceding three months (exception: acute ischemic stroke within 4.5 hours, treated with thrombolytic therapy)- presence of a cerebral vascular malformation- known primary or metastatic intracranial malignancy- symptoms or signs suggestive of an aortic dissection- a bleeding diathesis or active bleeding, with the exception of menses- significant closed-head or facial trauma within the preceding three months- intracranial or intraspinal surgery within 2 months- uncontrolled hypertension at presentation (unresponsive to emergency treatment) "}, {"type": "note", "data": "RELATIVE CONTRAINDICATIONS FOR ALTEPLASE- history of chronic, severe, poorly controlled hypertension- uncontrolled hypertension at presentation (SBP greater than 180 mmHg and/or DBP greater than 110 mmHg)- history of ischemic stroke more than three months previously- dementia- traumatic or prolonged (greater than 10 min) CPR- Any known intracranial disease that is not an absolute contraindication- major surgery within the preceding three weeks- recent (2 to 4 weeks) internal bleeding- active peptic ulcer- non-compressible vascular punctures- pregnancy- current use of anticoagulants "}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "T;N, Remove jewelry or other extraneous material from the body part. Let skin air dry, do not rub; protect from direct trauma. Avoid tobacco and alcohol."}, {"type": "order", "data": "Wound Assessment", "value": "checked"}, {"type": "sentence", "data": "T;N, Daily, Monitor frostbite affected areas and document skin changes and any evidence of cyanosis or hemorrhagic blisters"}, {"type": "order", "data": "Wound Care", "value": "checked"}, {"type": "sentence", "data": "T;N, Debridement, Physician to debride and aspirate clear blisters (leave hemorrhagic blisters intact)"}, {"type": "order", "data": "Wound Care", "value": "checked"}, {"type": "sentence", "data": "T;N, Dressing Change, Daily, Apply Aloe Vesta Protective ointment and Mepitel dressing"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "T;N, Elevate affected parts and avoid ambulation on thawed lower extremity (unless only distal toes are affected)"}, {"type": "order", "data": "Encourage Oral Fluids", "value": "checked"}, {"type": "note", "data": "Placeholder: Daily hydrotherapy of luke warm water (39\u00baC) once practicioner that administers is identified"}, {"type": "order", "data": "Refer to", "value": ""}, {"type": "sentence", "data": "T;N, Provincial nursing reference guide for Frostbite Injury for further information at www.clwk.ca in Wound Resources"}, {"type": "note", "data": "iloprost monitoring "}, {"type": "order", "data": "Blood Pressure (BP)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, For iloprost monitoring"}, {"type": "order", "data": "Heart Rate (HR)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, For iloprost monitoring"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Sodium Chloride 0.9% Bolus", "value": "checked"}, {"type": "sentence", "data": "mL, IV BOLUS, Injection, Daily, PRN, Other (see Comment)"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Do not give ibuprofen if receiving alteplase or enoxaparin "}, {"type": "order", "data": "ibuprofen", "value": ""}, {"type": "sentence", "data": "400 mg, PO, Tab, q6hr, PRN, Pain, for 180 day(s)"}, {"type": "order", "data": "morphine", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Tab, q4hr, PRN, Pain, for 5 day(s)"}, {"type": "order", "data": "morphine", "value": ""}, {"type": "sentence", "data": "4 mg, IV Push, Injection, q4hr, Pain, for 5 day(s)"}, {"type": "order", "data": "fentanyl 0.05 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "50 mcg, IV, Injection, q5min, PRN, Pain, Severe, for 5 day(s)"}, {"type": "order", "data": "Td Adsorbed 5 units-2units/0.5 mL intramuscular suspension", "value": ""}, {"type": "sentence", "data": "0.5 mL, IM, Injection, Once"}, {"type": "note", "data": "Physician must be available for at least 10 minutes following the initiation of any infusion or dosage increase "}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "T;N, Frostbite Treatment:Rewarming;  Rapidly re-warm frostbite affected parts in 1000 mL of water 39c with 30 mL of chlorhexidine gluconate 2% isopropyl alcohol 4% (Stanhexidine or equivalent) until area becomes soft and pliable to the touch (30 minutes)"}, {"type": "note", "data": "For grade 2 to 4 frostbite, start iloprost IV infusion within 72 hours of rewarming.Select target infusion rate:- 40 to 50 kg: 100 nanogram (ng)/min- 51 to 74 kg: 133.3 nanogram (ng)/min- 75 kg or more: 166.6 nanogram (ng)/min "}, {"type": "note", "data": "Placeholder for iloprost 50 mcg IV infusion daily x 5 days"}, {"type": "note", "data": "For grade 4 frostbite and less than 24 hours since rewarming: "}, {"type": "note", "data": "Placeholder for alteplase infusion"}, {"type": "note", "data": "If receiving alteplase, select one of the following: "}, {"type": "note", "data": "eGFR 30 mL/min or greater and less than 75 years: "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, IV BOLUS, Injection, Once"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, SubQ, Injection, q12hr(sched), for 72 hr"}, {"type": "note", "data": "eGFR 30 mL/min or greater and 75 years or older: "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "0.75 mg/kg, SubQ, Injection, q12hr(sched), for 72 hr"}, {"type": "note", "data": "eGFR less than 30 mL/min and less than 75 years: "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, IV BOLUS, Injection, Once"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, SubQ, Injection, q24hr(sched), for 72 hr"}, {"type": "note", "data": "eGFR less than 30 mL/min and 75 years or older: "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, SubQ, Injection, q24hr(sched), for 72 hr"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC w/ Diff", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "INR", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "order", "data": "PTT", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "note", "data": "Placeholder for E7 (Na, K, CO2, Chloride, Creatinine, Urea Glucose) and blood type/screen once decision on panels is made"}, {"type": "order", "data": "BUN", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT collect, T;N, Once"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Consult to Physician", "value": ""}, {"type": "sentence", "data": "T;N, Internist - General"}, {"type": "order", "data": "Consult to Physician", "value": ""}, {"type": "sentence", "data": "T;N, General Surgery"}, {"type": "order", "data": "Consult to Critical Care", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Consult to Enterostomal Therapist", "value": ""}, {"type": "sentence", "data": "T;N, NSWOC (Nurse Specialized in Wound, Ostomy and Continence) as available"}]
